Zuranolone for postpartum depression: Hope, hype or both?
While mothers with postpartum depression have always faced barriers accessing the care they need, things have been particularly bad since the onset of the COVID-19 pandemic.
Sep 1, 2023
0
32
Organic Chemical: 3 alpha Hydroxy 5 alpha pregnan 20 one
Medical news and research articles
Q&A: Postpartum depression drug heralds new hope for moms, says physician
The Food and Drug Administration announced Friday its approval of the new drug zuranolone for postpartum depression. The once-daily pill, meant for short-term use, may help those who struggle with the serious, sometimes life-threatening ...
Aug 7, 2023
0
47
Study finds neurosteroid deficits lead to depressed behavior
The latest generation of antidepressants relieves symptoms by mimicking steroids produced by the brain to ensure neurons are effectively talking to each other. How these neurosteroids are linked to depression and why they ...
Feb 13, 2023
0
67
Potential oral capsule drug for neurological conditions a step closer
An Australian drug delivery technology, developed by Monash University researchers in partnership with PureTech Health plc (Nasdaq: PRTC, LSE: PRTC), has today released results from a multipart Phase 1 trial of the prodrug ...
Dec 21, 2022
0
64
How pregnancy changes the parental brain
Pregnancy and birthing have profound, often long-lasting, effects on brain physiology, mood and behavior. New findings on the neurobiology of the maternal experience were presented at Neuroscience 2022, the annual meeting ...
Nov 9, 2022
0
31
Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice
In the United States, approximately 1.2 million people are living with human immunodeficiency virus type-1 (HIV-1), with men accounting for the majority of cases (~75%). About half of HIV-infected individuals are 50 years ...
Jul 28, 2022
0
96
